Skip to main content

Advertisement

SpringerLink
Log in

DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The ability of a promoter to initiate transcription is important for the control of gene expression. Mutations in the DNA polymerase beta (po1β) promoter may affect the transcription of this gene; however, the relationship between these mutations and the upregulation of the expression of po1β remains unclear. Therefore, in the present study, three po1β promoter mutants (M1, −37 C→A; M2, −114 G→A, −37 C→A; M3, −194 T→C) were generated to examine the effect of promoter mutations on polβ gene expression and sensitivity to cisplatin. We found that the M1 and M2 mutant polβ promoter constructs showed higher RLA than the wild-type polβ promoter (P < 0.01), whereas the activity of the M3 polβ promoter did not differ significantly from that of the wild-type polβ promoter (P > 0.05). The expression levels of polβ mRNA and protein were significantly higher (P < 0.01) and the sensitivity to cisplatin was significantly lower (P < 0.05) in Eca9706−/−-M1 and Eca9706−/−-M2 cells than in Eca9706−/−-W. The expression levels of polβ mRNA and protein and the sensitivity to cisplatin were not significantly different between Eca9706−/−-M3 and Eca9706−/−-W cells (P > 0.05).These results revealed that specific mutations of the polymerase beta gene promoter significantly enhanced the gene’s transcriptional activity. These mutations correspondingly increased the gene’s mRNA and protein product, at the same time reduced the esophageal cancer cells’ sensitivity to cisplatin

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Idriss HT, Al-Assar O, Wilson SH (2002) DNA polymerase beta. Int J Biochem Cell Biol 34(4):321–324

    Article  PubMed  CAS  Google Scholar 

  2. Bergoglio V, Pillaire MJ, Lacroix-Triki M et al (2002) Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res 62:3511–3514

    PubMed  CAS  Google Scholar 

  3. Canitrot Y, Frechet M, Servant L et al (1999) Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J 13:1107–1111

    PubMed  CAS  Google Scholar 

  4. Canitrot Y, Cazaux C, Freehet M et al (1998) Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci USA 95:12586–12590

    Article  PubMed  CAS  Google Scholar 

  5. Sliwinski T, Ziemba P, Morawiec Z et al (2007) Polymorphisms of the DNA polymerase beta gene in breast cancer. Breast Cancer Res Treat 103(2):161–166

    Article  PubMed  CAS  Google Scholar 

  6. Lang T, Dalal S, Chikova A et al (2007) The E295K DNA polymerase beta gastric cancer-associated variant interferes with base excision repair and induces cellular transformation. Mol Cell Biol 27(15):5587–5596

    Article  PubMed  CAS  Google Scholar 

  7. Tan XH, Zhao M, Pan KF et al (2005) Frequent mutation related with overexpression of DNA polymerase beta in primary tumors and precancerous lesions of human stomach. Cancer Lett 220(1):101–114

    Article  PubMed  CAS  Google Scholar 

  8. Eydmann ME, Knowles MA (1997) Mutation analysis of 8p gene POLB and PPP2CB in bladder cancer. Cancer Genet Cytogenet 93(2):167–171

    Article  PubMed  CAS  Google Scholar 

  9. Dalal S, Hile S, Eckert KA, Sun KW et al (2005) Prostate-cancer-associated I260M variant of DNA polymerase beta is a sequence-specific mutator. Biochemistry 44(48):15664–15673

    Article  PubMed  CAS  Google Scholar 

  10. Zhao GQ, Wang T, Zhao Q et al (2005) Mutation of DNA polymerase beta in esophageal carcinoma of different regions. World J Gastroenterol 11(30):4618–4622

    PubMed  CAS  Google Scholar 

  11. Dong Z, Zhao G, Zhao Q et al (2002) A study of DNA polymerase β mutation in human esophageal cancer. Natl Med J China 82(13):899–902

    CAS  Google Scholar 

  12. Zhao G, Wang T, Zhao M et al (2005) Detection of DNA polymerase β mRNA in esophageal carcinoma tissue. J Zhengzhou Univ (Med Sci) 40(4):603–605

    CAS  Google Scholar 

  13. Dong ZM, Zheng NG, Wu JL, Li SK, Wang YL (2006) Difference in expression level and localization of DNA polymerase beta among human esophageal cancer focus, adjacent and corresponding normal tissues. Dis Esophagus 19:172–176

    Article  PubMed  CAS  Google Scholar 

  14. Albertella MR, Lau A, O’Connor MJ (2005) The overexpression of specialized DNA polymerases in cancer. DNA Repair (Amst) 4(5):583–593

    Article  CAS  Google Scholar 

  15. Sobol RW, Foley JF, Nyska A et al (2003) Regulated over-expression of DNA polymerase beta mediates early onset cataract in mice. DNA Repair (Amst) 2(5):609–622

    Article  CAS  Google Scholar 

  16. Li Y-B, Yu Y-L, Zhao G-Q, Wang H, Dong Z-M (2008) Mutation analysis of DNA polymerase β gene promoter in human esophageal cancer. World Chi J Dig 16(23):2649–2652

    CAS  Google Scholar 

  17. Feng L, Ma Y, Zhao G, Li M, Sun S, Dong Z, Huang Y (2010) Establishment and characterization of DNA pol β knockout human esophageal carcinoma cell line EC9706. Life Sci J 7(2):13–18

    Google Scholar 

  18. Widen SG, Kedar P, Wilson SH (1988) Human beta-polymerase gene. Structure of the 5′-flanking region and active promoter. J Biol Chem 263(32):16992–16998

    PubMed  CAS  Google Scholar 

  19. Prasad R, Shock DD, Beard WA et al (2010) Passing the baton: substrate channeling in mammalian base excision repair pathways. J Biol Chem 285:40479–40488

    Article  PubMed  CAS  Google Scholar 

  20. Shrivastav N, Li D, Essigmann JM (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31:59–70

    Article  PubMed  CAS  Google Scholar 

  21. Kidane D, Dalal S, Keh A, Liu Y, Zelterman D, Sweasy JB (2011) DNA polymerase beta is critical for genomic stability of sperm cells. DNA Repair 10:390–397

    Article  PubMed  CAS  Google Scholar 

  22. Asagoshi K, Liu Y, Masaoka A et al (2010) DNA polymerase beta dependent long patch base excision repair in living cells. DNA Repair 9:109–119

    Article  PubMed  CAS  Google Scholar 

  23. Vermeulen C, Verwijs-Janssen M, Begg AC, Vens C (2008) Cell cycle phase dependent role of DNA polymerase β in DNA repair and survival after ionizing radiation. Radiother Oncol 86:391–398

    Article  PubMed  CAS  Google Scholar 

  24. Neijenhuis S, Verwijs-Janssen M, Kasten-Pisula U et al (2009) Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase β. DNA Repair (Amst) 8:336–346

    Article  CAS  Google Scholar 

  25. Chan K, Houlbrook S, Zhang QM, Harrison M, Hickson ID, Dianov GL (2007) Overexpression of DNA polymerase beta results in an increased rate of frameshift mutations during base excision repair. Mutagenesis 22(3):183–188

    Article  PubMed  CAS  Google Scholar 

  26. Nicolay NH, Helleday T, Sharma RA (2012) Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment. Curr Mol Pharmacol 5(1):54–67

    PubMed  CAS  Google Scholar 

  27. Canitrot Y, Cazaux C, Fréchet M, Bouayadi K, Lesca C, Salles B, Hoffmann JS (1998) Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs. Proc Natl Acad Sci 95(21):12586–12590

    Article  PubMed  CAS  Google Scholar 

  28. Bergoglio V, Canitrot Y, Hogarth L, Minto L, Howell SB, Cazaux C, Hoffmann JS (2001) Enhanced expression and activity of DNA polymerase beta in human ovarian tumor cells: impact on sensitivity towards antitumor agents. Oncogene 20(43):6181–6187

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by National Natural Science Foundation of China (81272188).

Author information

Authors and Affiliations

  1. Department of Hemato-tumor, The First Affiliated Hospital of Henan University of TCM, Zhengzhou, 450000, People’s Republic of China

    Tao Wang

  2. The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People’s Republic of China

    Tao Wang

  3. Department of Immunology & Microbiology, Henan Medical College for Staff and Workers, Zhengzhou, 450000, People’s Republic of China

    Yunyun Ma

  4. College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, People’s Republic of China

    Wenqiao Zang, Min Li, Xiaoyan Xuan, Na Wang, Yuebai Li, Ziming Dong & Guoqiang Zhao

  5. Department of Neurological Rehabilitation, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, People’s Republic of China

    Rui Wu

Authors
  1. Tao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenqiao Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yunyun Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoyan Xuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Na Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rui Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuebai Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ziming Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Guoqiang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Ziming Dong or Guoqiang Zhao.

Additional information

Tao Wang and Wenqiao Zang contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, T., Zang, W., Ma, Y. et al. DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment. Mol Biol Rep 40, 1333–1339 (2013). https://doi.org/10.1007/s11033-012-2177-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2177-8

Keywords

Search

Navigation